Patient-Derived Non-Muscular Invasive Bladder Cancer Xenografts of Main Molecular Subtypes of the Tumor for Anti-Pd-l1 Treatment Assessment

Background: Establishment of heterotopic patient-derived xenografts of primary and relapsed non-muscular invasive bladder cancer (NMIBC) to explore the biological property of PD-L1 signaling that may impact bladder tumor growth in humanized animals. Methods: Tumor cells of luminal, basal, and p53 su...

Descripción completa

Detalles Bibliográficos
Autores principales: Blinova, Ekaterina, Roshchin, Dmitry, Kogan, Evgenya, Samishina, Elena, Demura, Tatiana, Deryabina, Olga, Suslova, Irina, Blinov, Dmitry, Zhdanov, Pavel, Osmanov, Usif, Nelipa, Mikhail, Kaprin, Andrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628037/
https://www.ncbi.nlm.nih.gov/pubmed/31159302
http://dx.doi.org/10.3390/cells8060526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628037/
https://www.ncbi.nlm.nih.gov/pubmed/31159302
http://dx.doi.org/10.3390/cells8060526

Ejemplares similares